Beijing Tiantan Hospital

NCT07526987

Phase 3Recruiting2026934 people14 Apr 2026clinicaltrials.gov

NCT07423975

Phase 2Not yet recruiting2026159 people20 Feb 2026clinicaltrials.gov

NCT07338175

Phase 3Recruiting20261,192 people13 Jan 2026clinicaltrials.gov

NCT07035405

Phase 3Not yet recruiting20257,500 people25 Jun 2025clinicaltrials.gov

NCT06563817

Phase 2Status unknown202453 people21 Aug 2024clinicaltrials.gov

NCT06316570

Phase 3Completed20241,382 people18 Mar 2024clinicaltrials.gov

NCT06308952

CollaboratorPhase 4Recruiting2024354 people13 Mar 2024clinicaltrials.gov

NCT06238115

Phase 2/3Completed2024192 people2 Feb 2024clinicaltrials.gov

NCT05982470

Phase 2Status unknown2023328 people8 Aug 2023clinicaltrials.gov

NCT05836740

Phase 3Completed20231,724 people1 May 2023clinicaltrials.gov

NCT05507645

Phase 3Completed20221,446 people19 Aug 2022clinicaltrials.gov

NCT05439356

Phase 3Completed20228,343 people30 Jun 2022clinicaltrials.gov

NCT05310968

Phase 4Completed2022970 people5 Apr 2022clinicaltrials.gov

NCT05141305

Phase 3Completed2022516 people2 Dec 2021clinicaltrials.gov

NCT04420351

CollaboratorPhase 3Completed20201,005 people9 Jun 2020clinicaltrials.gov

NCT04078737

Phase 3Completed20196,412 people6 Sept 2019clinicaltrials.gov

NCT03871517

Phase 4Completed20195,438 people12 Mar 2019clinicaltrials.gov

NCT03635749

Phase 3Status unknown20186,100 people17 Aug 2018clinicaltrials.gov

China Antihypertensive Trial in Acute Ischemic Stroke II

CollaboratorPhase 3Completed20184,810 people27 Mar 2018clinicaltrials.gov

NCT03392545

Phase 1Status unknown201830 people8 Jan 2018clinicaltrials.gov